))
What Went Wrong? The Failure of MetMab with Tarceva in Advanced Non-Small Cell Lung Cancer
Manage episode 153141031 series 1082357
Content provided by cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by cancerGRACE - H. Jack West, MD, CancerGRACE - H. Jack West, and MD or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
"Dead negative," is how Dr. Nasser Hanna describes results of a phase 3 study that examined how patients with high MET expression did on the drug MetMab (onartuzumab).
307 episodes
Share
